Single company EIS

Single company EIS deals are private offers for experienced investors. 

They give you an opportunity to invest directly in a particular company you consider commercially compelling and able to deliver attractive returns, with the benefit of EIS tax relief. Please remember, tax rules can change and benefits depend on circumstances.

So, unlike with EIS funds where the asset manager makes the investment decisions on your behalf, you are in control, you decide which company to back. Get it right, and the reward could be considerable. 

But one cannot expect to get it right each time. You are investing in early-stage companies – inevitably some will fail. To help mitigate this, it might be wise to diversify and spread your EIS investments each year over a number of single companies.

How could you access single company deals? 

Thousands of EIS-qualifying companies raise funds. The latest figures show a record 3,920 businesses raised nearly £2 billion under EIS in just one year (2017/18). 

We aim to offer a selection of quality EIS opportunities you often wouldn't be able to get elsewhere. Each has been carefully assessed, either by Wealth Club or by reputable and established counterparties. To help you make your own informed decisions, we provide you with insight and comment on each offer. This is free to Wealth Club members. 

Important: all the EIS single company deals listed below aim to allot shares before 5 April 2021, so you should be able to use the tax relief in the 2020/21 tax year and/or carry back to the 2019/20 tax year. Tax rules can change and benefits depend on circumstances. 

  • Our choice

    Inotec EIS

    Exclusive opportunity to co-invest alongside Amadeus Capital Partners and Abcam’s Jonathan Milner in a global MedTech wound care business with unprecedented healing rates. Already used by the US Department of Veterans Affairs, patented NATROX® wearable technology applies oxygen therapy. Wounds are three times more likely to heal, and the treatment can be 38% cheaper than standard care. This could potentially be the last opportunity for investors to invest under EIS. This private offer is only available through Wealth Club. Download research report and prefill application online.

    Read more about Inotec EIS
    Type
    Single company
    Sector
    Healthcare & Technology
    Target return
    10x (60% IRR)
    Funds raised / sought
    £1.0 million / £1.0 million
    Minimum investment
    £10,127
    Deadline
    29 Jan 2021 for next close
  • Kemuri EIS

    Kemuri Limited is an award-winning health platform that utilises machine learning and innovative data analysis software to support safer independent living for vulnerable and older people.

    Read more about Kemuri EIS
    Type
    Single company
    Sector
    Technology
    Target return
    10.7x
    Funds raised / sought
    £2.7 million / £3.0 million
    Minimum investment
    £20,000
    Deadline
    Limited capacity remaining
  • Mojo Mortgages EIS

    Mojo Mortgages addresses the pain point of the mortgage application process using technology and automation. Read more and prefill application online

    Read more about Mojo Mortgages EIS
    Type
    Single company
    Sector
    Technology
    Target return
    3.2x
    Funds raised / sought
    £1.0 million sought
    Minimum investment
    £21,285
    Deadline
    22 Jan 2021 for next allotment
  • SageTech Medical EIS

    Exclusive Wealth Club allocation: MedTech business with patented technology capturing waste anaesthetic gas, that could help hospitals save £millions and cut emissions. SageTech has developed a way to capture, extract and purify waste anaesthetic agents used during surgery. Read more and prefill application online.

    Read more about SageTech Medical EIS
    Type
    Single company
    Sector
    Healthcare & Technology
    Target return
    6x (43% IRR)
    Funds raised / sought
    £500,000 sought
    Minimum investment
    £20,650
    Deadline
    5 Feb 2021 for first close
  • Wi5 EIS

    Wi5 Technologies Limited (“Wi5” or the “Company”) offers a best-in-class Order & Pay solution recognised as one of the most reliable on the market and easiest for both businesses and customers to use. In a mobile pay market estimated even before the pandemic to be worth $1 trillion globally by 2024, demand for the technology is now accelerated by its crucial advantage of helping venues comply with restrictive Covid-19 regulations. Wi5 is now raising £5 million under EIS to deliver its technology to thousands more locations, both in the UK and internationally. Read more and apply online

    Read more about Wi5 EIS
    Type
    Single company
    Sector
    Technology
    Target return
    32.1x
    Funds raised / sought
    £4.2 million / £5.0 million
    Minimum investment
    £20,000
    Deadline
    29 Jan 2021